Company: BCDRF
Filing Date: 2025-01-02
Form Type: 6-K
Source: 0000891478-25-000002
Chunk: 47

Company: Banco Santander, S.A.
Filing Date: 2025-01-02
Form: 6-K
Chunk 47
---
ase of EUR 45 million in the cumulative actuarial losses relating to the Group's businesses in Mexico, mainly due to the increase in the discount rate (from 9.25% to 10.25%).

The other modification in accumulated actuarial profit or losses is a decrease of EUR 31 million as a result of the evolution of exchange rates and other movements.

#### e)
Other comprehensive income - Items not reclassified to profit or loss – Changes in the fair value of equity instruments measured at fair value with changes in other comprehensive income

Includes the net amount of unrealised fair value changes in equity instruments at fair value with changes in other comprehensive income.

Below is a breakdown of the composition of the balance as of 30 September 2024 and 31 December 2023 under 'Other comprehensive income - Items not reclassified to profit or loss - Changes in the fair value of equity instruments measured at fair value with changes in other comprehensive income' depending on the geographical origin of the issuer:

|                        |     | EUR million       |     |     |                    |        |     |                                |        |     |            |       |     |                   |     |     |                    |        |     |                                |        |     |            |       |
|                        |     | 30-09-2024        |     |     |                    |        |     |                                |        |     |            |       |     | 31-12-2023        |     |     |                    |        |     |                                |        |     |            |       |
|                        |     | Revaluation gains |     |     | Revaluation losses |        |     | Net revaluation gains/(losses) |        |     | Fair value |       |     | Revaluation gains |     |     | Revaluation losses |        |     | Net revaluation gains/(losses) |        |     | Fair value |       |
| Equity instruments     |     |                   |     |     |                    |        |     |                                |        |     |            |       |     |                   |     |     |                    |        |     |                                |        |     |            |       |
| Domestic               |     |                   |     |     |                    |        |     |                                |        |     |            |       |     |                   |     |     |                    |        |     |                                |        |     |            |       |
| Spain                  |     |                   |  39 |